Hjem › Skjoldbruskkjertelkreft › Texas › Houston
Kliniske studier for Skjoldbruskkjertelkreft i Houston, TX
12 studier for Skjoldbruskkjertelkreft søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- UT MD Anderson Cancer Center, Houston
Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
RekruttererObservasjonsstudie
- MD Anderson Cancer Center, Houston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
Rekrutterer
- The University of Texas M. D. Anderson Cancer Center, Houston
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
RekruttererFase 2
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- M D Anderson Cancer Center, Houston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Rekrutterer
- M D Anderson Cancer Center, Houston
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
RekruttererFase 2
- MD Anderson Cancer Center, Houston
Skjoldbruskkjertelkreft-studier i andre byer
- Washington, DC10 studier
- New York City, NY9 studier
- Boston, MA6 studier
- Philadelphia, PA6 studier
- Nashville, TN5 studier
- Durham, NC5 studier
- Los Angeles, CA5 studier
- San Francisco, CA4 studier
- San Antonio, TX4 studier
- Minneapolis, MN4 studier
- St. Louis, MO4 studier
- Memphis, TN4 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.